EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis

Rachel L Paterson iD, Marco P La Manna iD, Victoria Arena De Souza, Andrew Walker iD, Dawn Gibbs-Howe, Rakesh Kulkarni iD, Joannah R Fergusson, Nitha Charles Mulakkal, Mauro Monteiro iD, Wilawan Bunjobpol, Marcin Dembek, Magdalena Martin-Urdiroz iD und 23 weitere

Proceedings of the National Academy of Sciences · 07.05.2024 · 121 (19)

DOI: 10.1073/pnas.2318003121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024-05. Verfasst von Rachel L Paterson und 34 weiteren Autor:innen. Beteiligte Einrichtung: Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Receptors, Antigen, T-Cell, Histocompatibility Antigens Class I, T-Lymphocytes. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NextGenerationEU, UKRI | Medical Research Council (MRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptides presented by HLA-E, a molecule with very limited polymorphism, represent attractive targets for T cell receptor (TCR)-based immunotherapies to circumvent the limitations imposed by the high polymorphism of classical HLA genes in the human population. Here, we describe a TCR-based bispecific molecule that potently and selectively binds HLA-E in complex with a peptide encoded by the inhA gene of Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis in humans. We reveal the biophysical and structural bases underpinning the potency and specificity of this molecule and demonstrate its ability to redirect polyclonal T cells to target HLA-E-expressing cells transduced with mycobacterial inhA as well as primary cells infected with virulent Mtb. Additionally, we demonstrate elimination of Mtb-infected cells and reduction of intracellular Mtb growth. Our study suggests an approach to enhance host T cell immunity against Mtb and provides proof of principle for an innovative TCR-based therapeutic strategy overcoming HLA polymorphism and therefore applicable to a broader patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisReceptors, Antigen, T-CellHistocompatibility Antigens Class IT-LymphocytesHumansHLA-E AntigensBacterial ProteinsTuberculosis

Stichwörter der Autor:innen

HLA-ET cell receptorimmunotherapytuberculosis

Substanzen

Receptors, Antigen, T-CellHistocompatibility Antigens Class IHLA-E AntigensBacterial Proteins

Autor:innen und Institutionen

  • Immunocore Ltd., Abingdon, Oxfordshire OX14 4RY, United Kingdom.
  • Department of Biomedicine, Neurosciences and Advanced Diagnostic, University of Palermo, Palermo 90127, Italy.
  • Central Laboratory of Advanced Diagnosis and Biomedical Research, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, University of Palermo, Palermo 90127, Italy.
  • National Institute for Health and Care Research, Biomedical Research Centre and Institute for Life Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom.

ORCID-Profile: Rachel L Paterson, Marco P La Manna, Andrew Walker, Rakesh Kulkarni, Mauro Monteiro, Magdalena Martin-Urdiroz, Diana J Garay-Baquero, Robert Pengelly, Praveen K Singh, Amanda P Woon, Mariolina Salio, Giusto Davide Badami, Paul Elkington, Francesco Dieli, Luis F Godinho

Förderung

  • Medical Research Council
  • NextGenerationEU
  • UKRI | Medical Research Council (MRC)

Zitieren

APA

Paterson, R. L., La Manna, M. P., Arena De Souza, V., Walker, A., Gibbs-Howe, D., Kulkarni, R., Fergusson, J. R., Mulakkal, N. C., Monteiro, M., Bunjobpol, W., Dembek, M., Martin-Urdiroz, M., Grant, T., Barber, C., Garay-Baquero, D. J., Tezera, L. B., Lowne, D., Britton-Rivet, C., Pengelly, R., …, & Godinho, L. F. (2024). An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences, 121(19). https://doi.org/10.1073/pnas.2318003121

Vancouver

Paterson RL, La Manna MP, Arena De Souza V, Walker A, Gibbs-Howe D, Kulkarni R, et al. An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences. 2024;121(19). doi:10.1073/pnas.2318003121

BibTeX
@article{Paterson2024,
  author = {Paterson, Rachel L and La Manna, Marco P and Arena De Souza, Victoria and Walker, Andrew and Gibbs-Howe, Dawn and Kulkarni, Rakesh and Fergusson, Joannah R and Mulakkal, Nitha Charles and Monteiro, Mauro and Bunjobpol, Wilawan and Dembek, Marcin and Martin-Urdiroz, Magdalena and Grant, Tressan and Barber, Claire and Garay-Baquero, Diana J and Tezera, Liku Bekele and Lowne, David and Britton-Rivet, Camille and Pengelly, Robert and Chepisiuk, Natalia and Singh, Praveen K and Woon, Amanda P and Powlesland, Alex S and McCully, Michelle L and Caccamo, Nadia and Salio, Mariolina and Badami, Giusto Davide and Dorrell, Lucy and Knox, Andrew and Robinson, Ross and Elkington, Paul and Dieli, Francesco and Lepore, Marco and Leonard, Sarah and Godinho, Luis F},
  title = {An HLA-E-targeted TCR bispecific molecule redirects T cell immunity against Mycobacterium tuberculosis},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {19},
  doi = {10.1073/pnas.2318003121}
}
Kostenlos starten →